from molecule to medicine

Hyperdrivesays...

Interesting sift, however, I'd challenge the closing comment that 'a major part of the profit is reinvested in new research'.

Marc-Andre Gagnon and Joel Lexicon produced a revealing peer-reviewed paper in December 2007, titled 'The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the U.S.' They concluded that drug companies are spending nearly twice as much on promotion as research and development.

"As a percent of U.S. domestic sales of $235.4 billion, promotion consumes 24.4% of the sales dollar versus 13.4% for on R&D. In light of these numbers one can safely argue that marketing is predominant over R&D in the pharmaceutical industry, contrary to industry's claim."

Now that really is sickening.

doremifasays...

"why would corporate research ever develop a cure when they can indefinitely milk new treatments."

Finding a cure, a silver bullet, is difficult (severe understatement). Finding a treatment is still beneficial to sufferers.


^Hyperdrive:

Wish I could disagree with you.

Send this Article to a Friend



Separate multiple emails with a comma (,); limit 5 recipients






Your email has been sent successfully!

Manage this Video in Your Playlists




notify when someone comments
X

This website uses cookies.

This website uses cookies to improve user experience. By using this website you consent to all cookies in accordance with our Privacy Policy.

I agree
  
Learn More